mortality/aging
• die between 8 and 12 months of age
|
growth/size/body
• mutants weight less than littermate controls after 4 and 5 months of age, for females and males, respectively
|
behavior/neurological
• decrease in rotarod performance first seen at 3 and 4 months of age for males and females, respectively
|
• at 3 months of age, mutants start to decrease their nocturnal activity and by 4 months, cycles of hyperactivity are seen and continue throughout their life span
|
cellular
• mutants exhibit 80% of mitochondrial respiratory complex IV (CIV) activity of control levels in the cortex at 1 month of age and 33% of control levels by 4 months of age
• mutants exhibit decreased CIV activity in the hippocampus as well
|
nervous system
• brain weight is normal at 1-4 months of age, however by 8 months of age, brains weigh about half of control weight
|
• severe cortical atrophy by 8 months of age
|
• neuronal cell death in the cingulate cortex at 4 months of age, but not earlier
|
• mutants show oxidative damage in the piriform cortex at 4 months of age and neuronal cell death at this time but not earlier
|
• mutants exhibit progressive encephalopathy, with small lesions in the piriform cortex at 4 months of age, lesions in the striatum, outer cortical layers and hippocampus by 6 months of age, and massive degeneration of the cortex by 8 months of age
|
• mutants consistently show neuronal cell death in the cingulate cortex, piriform cortex, and hippocampus/dentate gyrus at 4 months of age, but not earlier
|
• the hippocampus/dentate gyrus and CA1 region shows neuronal loss at 4 months of age
|
• mutants show metabolic changes in the brain, with elevated levels of lactate and a decrease in n-acetyl aspartate
|
• mutants exhibit a dramatic increase in GFAP immunoreactivity in the cortex and somewhat smaller increase in the hippocampus and piriform cortex at 4-5 months of age, indicating reactive glia
|
homeostasis/metabolism
• mutants exhibit decreased mitochondrial respiratory complex IV enzymatic activity in the cortex and hippocampus
|
Mouse Models of Human Disease |
DO ID | OMIM ID(s) | Ref(s) | |
cytochrome-c oxidase deficiency disease | DOID:3762 |
OMIM:PS220110 |
J:188773 |